02 The FDA decides whether to accept the filing Roughly 60 days after submission, the agency decides whether the application is complete enough to review
Its lightweight, non-greasy texture absorbs easily into the skin, leaving a smooth, fresh finish
Similarly, any signs of allergic reaction , including swelling of the face, lips, or throat, trouble breathing, or a severe rash should be reported immediately
Private Plan Outlook Alberta Blue Cross's 2026 drug pipeline report identifies GLP-1 therapies as a major cost driver, stating that while a semaglutide generic is expected in mid-2026, overall GLP-1 therapy plan spend is unlikely to decline in future years due to growing use and continued expansion of GLP-1 therapies